OBJECTIVE: To determine whether implementation of provider-initiated human immunodeficiency virus (HIV) counseling would increase the proportion of tuberculosis (TB) patients who received HIV counseling and testing. DESIGN: Cluster-randomized trial with clinic as the unit of randomization. SETTING: Twenty, medium-sized primary care TB clinics in the Nelson Mandela Metropolitan Municipality, Port Elizabeth, Eastern Cape Province, South Africa. SUBJECTS: A total of 754 adults (18 years and older) newly registered as TB patients in the 20 study clinics. INTERVENTION: Implementation of provider-initiated HIV counseling and testing. MAIN OUTCOME MEASURES: Percentage of TB patients HIV counseled and tested. SECONDARY: Percentage of patients with HIV test positive, and percentage of those who received cotrimoxazole and who were referred for HIV care. RESULTS: : A total of 754 adults newly registered as TB patients were enrolled. In clinics randomly assigned to implement provider-initiated HIV counseling and testing, 20.7% (73/352) patients were counseled versus 7.7% (31/402) in the control clinics (P = 0.011), and 20.2% (n = 71) versus 6.5% (n = 26) underwent HIV testing (P = 0.009). Of those patients counseled, 97% in the intervention clinics accepted testing versus 79% in control clinics (P = 0.12). The proportion of patients identified as HIV infected in intervention clinics was 8.5% versus 2.5% in control clinics (P = 0.044). Fewer than 40% of patients with a positive HIV test were prescribed cotrimoxazole or referred for HIV care in either study arm. CONCLUSIONS:Provider-initiated HIV counseling significantly increased the proportion of adult TB patients who received HIV counseling and testing, but the magnitude of the effect was small. Additional interventions to optimize HIV testing for TB patients urgently need to be evaluated.
RCT Entities:
OBJECTIVE: To determine whether implementation of provider-initiated human immunodeficiency virus (HIV) counseling would increase the proportion of tuberculosis (TB) patients who received HIV counseling and testing. DESIGN: Cluster-randomized trial with clinic as the unit of randomization. SETTING: Twenty, medium-sized primary care TB clinics in the Nelson Mandela Metropolitan Municipality, Port Elizabeth, Eastern Cape Province, South Africa. SUBJECTS: A total of 754 adults (18 years and older) newly registered as TB patients in the 20 study clinics. INTERVENTION: Implementation of provider-initiated HIV counseling and testing. MAIN OUTCOME MEASURES: Percentage of TB patientsHIV counseled and tested. SECONDARY: Percentage of patients with HIV test positive, and percentage of those who received cotrimoxazole and who were referred for HIV care. RESULTS: : A total of 754 adults newly registered as TB patients were enrolled. In clinics randomly assigned to implement provider-initiated HIV counseling and testing, 20.7% (73/352) patients were counseled versus 7.7% (31/402) in the control clinics (P = 0.011), and 20.2% (n = 71) versus 6.5% (n = 26) underwent HIV testing (P = 0.009). Of those patients counseled, 97% in the intervention clinics accepted testing versus 79% in control clinics (P = 0.12). The proportion of patients identified as HIV infected in intervention clinics was 8.5% versus 2.5% in control clinics (P = 0.044). Fewer than 40% of patients with a positive HIV test were prescribed cotrimoxazole or referred for HIV care in either study arm. CONCLUSIONS: Provider-initiated HIV counseling significantly increased the proportion of adult TB patients who received HIV counseling and testing, but the magnitude of the effect was small. Additional interventions to optimize HIV testing for TB patients urgently need to be evaluated.
Authors: A Van Rie; M Sabue; N Jarrett; D Westreich; F Behets; J Kokolomani; E R Bahati Journal: Int J Tuberc Lung Dis Date: 2008-03 Impact factor: 2.373
Authors: Lara R Fairall; Merrick Zwarenstein; Eric D Bateman; Max Bachmann; Carl Lombard; Bosielo P Majara; Gina Joubert; Rene G English; Angeni Bheekie; Dingie van Rensburg; Pat Mayers; Pat Myers; Annatjie C Peters; Ronald D Chapman Journal: BMJ Date: 2005-10-01
Authors: David M Silvestri; Kayvon Modjarrad; Meridith L Blevins; Elizabeth Halale; Sten H Vermund; Jeffry P McKinzie Journal: J Acquir Immune Defic Syndr Date: 2011-01-01 Impact factor: 3.731
Authors: Eric D McCollum; Geoffrey A Preidis; Mark M Kabue; Emmanuel B M Singogo; Charles Mwansambo; Peter N Kazembe; Mark W Kline Journal: PLoS One Date: 2010-03-10 Impact factor: 3.240
Authors: Alexander J Stockdale; Joseph Nkuranga; M Estée Török; Brian Faragher; David G Lalloo Journal: Trop Med Int Health Date: 2013-04-17 Impact factor: 2.622
Authors: R Baggaley; B Hensen; O Ajose; K L Grabbe; V J Wong; A Schilsky; Y-R Lo; F Lule; R Granich; J Hargreaves Journal: Bull World Health Organ Date: 2012-06-27 Impact factor: 9.408